CHO Integration Sites for Stable Recombinant Protein Expression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing mammalian expression systems, particularly Chinese hamster ovary (CHO) cell lines, face challenges in achieving stable and efficient integration and expression of recombinant proteins due to variations in expression levels and genetic instability at random integration sites, especially when integrating additional genes like antibody chains.
Innovation Solution
Integration of exogenous nucleic acids at specific chromosomal loci in CHO cells using expression-enhancing nucleotide sequences, such as SEQ ID NO: 1 or SEQ ID NO: 4, which are at least 90% identical, and incorporating recombinase recognition sites like LoxP, Lox511, and Cre recombinase for targeted recombination to enhance expression and stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If exogenous nucleic acids are integrated at random chromosomal loci in CHO cells, then gene transfer efficiency is achieved, but expression stability and consistency deteriorate due to position effects and local genetic factors
Solution Approach 1:
The patent pre-characterizes and identifies specific chromosomal loci in CHO cells that have been proven to support stable and high-level expression of recombinant proteins. These predetermined safe harbor sites are established before actual gene transfer, allowing researchers to target integration to these pre-validated locations rather than relying on random integration, thereby ensuring both efficient gene transfer and stable long-term expression.
Solution Approach 2:
The patent employs targeted integration strategies that use specific chromosomal loci as intermediary sites between the random integration process and the final stable expression outcome. These designated safe harbor sites act as controlled intermediaries that receive integrated transgenes and provide a stable genetic environment for consistent protein production, eliminating the harmful position effects of random integration.
2Adaptability or versatility
If additional genes are integrated into CHO cell lines for multispecific antibody production, then functional versatility is improved, but genetic stability and expression consistency deteriorate due to increased position effects
Solution Approach 1:
The patent segments the chromosomal genome into distinct functional zones, designating specific chromosomal loci as safe harbor sites that can accommodate multiple integrated genes without interfering with each other's expression. This segmentation allows multiple genes for multisspecific antibodies to be integrated at predetermined locations, maintaining genetic stability while achieving functional versatility.
Solution Approach 2:
The patent identifies and utilizes specific chromosomal loci with unique local genetic properties that are favorable for stable gene expression. These localized safe harbor sites have specific characteristics (such as open chromatin structure, appropriate epigenetic marks, and favorable neighboring genes) that create an optimal microenvironment for consistent expression of integrated transgenes, even when multiple genes are present.
3Reliability
If targeted integration at specific chromosomal loci is implemented, then expression stability is improved, but integration precision requirements increase
Solution Approach 1:
The patent performs preliminary characterization of chromosomal loci to identify safe harbor sites with proven stable expression properties before attempting targeted integration. This advance preparation and mapping of suitable integration sites reduces the precision burden during actual gene transfer, as researchers can target these pre-identified locations using standard homology-directed repair methods without requiring ultra-precise targeting to obscure sequences.
Data Source
AI summary
Expression-enhancing nucleotide sequences for eukaryotic expressions systems are provided that allow for enhanced and stable expression of recombinant proteins in eukaryotic cells. Genomic integration sites providing enhanced expression and methods of use thereof are provided for expression of a gene of interest in a eukaryotic cell. Chromosomal loci, sequences, and vectors are provided for enhanced and stable expression of genes in eukaryotic cells.